FOXO3 and non-small cell lung carcinoma: Previously, reduction of FOXO3a, microRNA-200c expression and overexpression of insulin growth factor 1 receptor and phosphorylated EGFR were associated with worse efficacy of EGFR-TKIs in NSCLC patients with EGFR-WT [11–14].